These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12412213)

  • 1. Treatment of recurrent oral aphthous ulcers with etanercept.
    Scheinberg MA
    Clin Exp Rheumatol; 2002; 20(5):733-4. PubMed ID: 12412213
    [No Abstract]   [Full Text] [Related]  

  • 2. Recalcitrant, recurrent aphthous stomatitis treated with etanercept.
    Robinson ND; Guitart J
    Arch Dermatol; 2003 Oct; 139(10):1259-62. PubMed ID: 14568829
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recurrent aphthosis: safety of low dose thalidomide].
    Gil H; Perrin S; Dupond JL; Meaux-Ruault N; Hafsaoui C; Limat S; Magy-Bertrand N
    Rev Med Interne; 2010 Jun; 31(6):403-5. PubMed ID: 20430488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of mucocutaneous Behçet's disease responding to etanercept.
    Sommer A; Altmeyer P; Kreuter A
    J Am Acad Dermatol; 2005 Apr; 52(4):717-9. PubMed ID: 15793540
    [No Abstract]   [Full Text] [Related]  

  • 5. Current and future use of anti-TNF agents in the treatment of autoimmune, inflammatory disorders.
    Calamia KT
    Adv Exp Med Biol; 2003; 528():545-9. PubMed ID: 12918761
    [No Abstract]   [Full Text] [Related]  

  • 6. Behçet's syndrome: from aetiology to treatment.
    Powell RJ
    Adv Exp Med Biol; 2003; 528():481-6. PubMed ID: 12918749
    [No Abstract]   [Full Text] [Related]  

  • 7. A patient with neuro-Behçet's disease is successfully treated with etanercept: further evidence for the value of TNFalpha blockade.
    Alty JE; Monaghan TM; Bamford JM
    Clin Neurol Neurosurg; 2007 Apr; 109(3):279-81. PubMed ID: 17174468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [10th International Conference on Behçet Syndrome. Berlin, June 27-29, 2002].
    Weschler B
    Rev Med Interne; 2002 Oct; 23(10):808-9. PubMed ID: 12428481
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and efficacy of etanercept in children with juvenile-onset Behcets disease.
    Cantarini L; Tinazzi I; Caramaschi P; Bellisai F; Brogna A; Galeazzi M
    Int J Immunopathol Pharmacol; 2009; 22(2):551-5. PubMed ID: 19505410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of resistant Behçet's disease with etanercept.
    Atzeni F; Sarzi-Puttini P; Capsoni F; Mecchia M; Marrazza MG; Carrabba M
    Clin Exp Rheumatol; 2005; 23(5):729. PubMed ID: 16173263
    [No Abstract]   [Full Text] [Related]  

  • 11. New therapies for ankylosing spondylitis: etanercept, thalidomide, and pamidronate.
    Davis JC; Huang F; Maksymowych W
    Rheum Dis Clin North Am; 2003 Aug; 29(3):481-94, viii. PubMed ID: 12951863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.
    Melikoglu M; Fresko I; Mat C; Ozyazgan Y; Gogus F; Yurdakul S; Hamuryudan V; Yazici H
    J Rheumatol; 2005 Jan; 32(1):98-105. PubMed ID: 15630733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory aphthous ulceration treated with thalidomide: a report of 10 years' clinical experience.
    Cheng S; Murphy R
    Clin Exp Dermatol; 2012 Mar; 37(2):132-5. PubMed ID: 22007681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent aphthous stomatitis of the Behçet's type: successful treatment with thalidomide.
    Eisenbud L; Horowitz I; Kay B
    Oral Surg Oral Med Oral Pathol; 1987 Sep; 64(3):289-92. PubMed ID: 3477744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.
    Jacobson JM; Greenspan JS; Spritzler J; Ketter N; Fahey JL; Jackson JB; Fox L; Chernoff M; Wu AW; MacPhail LA; Vasquez GJ; Wohl DA
    N Engl J Med; 1997 May; 336(21):1487-93. PubMed ID: 9154767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents.
    Seyahi E; Ozdogan H; Celik S; Ugurlu S; Yazici H
    Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S99-103. PubMed ID: 17067437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The short-term efficacy and safety treatment study of recurrent uveitis in Behcet disease with etanercept].
    Zhang MF; Zhao C; Wen X; Du H; Zhao Y
    Zhonghua Yan Ke Za Zhi; 2010 Feb; 46(2):145-50. PubMed ID: 20388349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Weight gain during treatment with thalidomide: a case report].
    Comte H; Béné J; Auffret M; Gautier S; Salle-Staumont D
    Therapie; 2014; 69(5):457-9. PubMed ID: 25285366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic agents and oral diseases -- an update on clinical applications.
    Georgakopoulou EA; Andreadis D; Arvanitidis E; Loumou P
    Acta Dermatovenerol Croat; 2013; 21(1):24-34. PubMed ID: 23683483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etanercept-induced hypertriglyceridemia during the treatment of recurrent aphthous stomatitis.
    Gonzalez-Lopez MA; Blanco R; Garcia-Ibarbia C; Gonzalez-Vela CM; Gonzalez-Gay MA
    Indian J Dermatol Venereol Leprol; 2013; 79(3):432-3. PubMed ID: 23619454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.